chr17:37880991:A>TGGCTGG Detail (hg19) (ERBB2)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr17:37,880,991-37,880,991 |
| hg38 | chr17:39,724,738-39,724,738 View the variant detail on this assembly version. |
HGVS
| Type | Transcript | Protein |
|---|---|---|
| RefSeq | NM_001005862.2:c.2230delinsTGGCTGG | NP_001005862.1:p.Met744delinsTrpLeuVal |
| NM_001289936.1:c.2230delinsTGGCTGG | NP_001276865.1:p.Met744delinsTrpLeuVal | |
| NM_004448.3:c.2320delinsTGGCTGG | NP_004439.2:p.Met774delinsTrpLeuVal |
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
| Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| lung non-small cell carcinoma | Dacomitinib | C |
|
|
Sensitivity/Response | Somatic | 3 | 25899785 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| Phase 2 trial of ERBB-inhibitor dacomitinib in stage IIIB/IV lung cancers with HER2 mutations or amp... | CIViC Evidence | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg19
- Position
- chr17:37,880,991-37,880,991
- Variant Type
- snv
- Reference Allele
- A
- Alternative Allele
- TGGCTGG
- Variant (CIViC) (CIViC Variant)
- M774DELINSWLV
- Transcript 1 (CIViC Variant)
- ENST00000269571.5
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/818
Genome browser